Literature DB >> 8618961

Molecular diversity of myofibrillar proteins: gene regulation and functional significance.

S Schiaffino1, C Reggiani.   

Abstract

Myofibrillar proteins exist as multiple isoforms that derive from multigene (isogene) families. Additional isoforms, including products of tropomyosin, myosin light chain 1 fast, troponin T, titin, and nebulin genes, can be generated from the same gene through alternative splicing or use of alternative promoters. Myofibrillar protein isogenes are differentially expressed in various muscle types and fiber types but can be coexpressed within the same fiber. Isogenes are regulated by transcriptional and posttranscriptional mechanisms; however, specific regulatory sequences and transcriptional factors have not yet been identified. The pattern of isogene expression varies during muscle development in relation to the different origin of myogenic cells and primary/secondary fiber generations and is affected by neural and hormonal influences. The variable expression of myofibrillar protein isoforms is a major determinant of the contractile properties of skeletal muscle fibers. The diversity among isomyosins is related to the differences in the parameters of chemomechanical transduction as ATP hydrolysis rate and shortening velocity. Troponin and tropomyosin isoforms determine the variable sensitivity to calcium, whereas titin isoforms dictate the elastic properties of muscle fibers at rest. Both myosin and troponin isoforms contribute to the differences in the resistance to fatigue of muscle fibers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8618961     DOI: 10.1152/physrev.1996.76.2.371

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  389 in total

1.  In vitro motility speed of slow myosin extracted from single soleus fibres from young and old rats.

Authors:  P Höök; X Li; J Sleep; S Hughes; L Larsson
Journal:  J Physiol       Date:  1999-10-15       Impact factor: 5.182

2.  The organization of the Golgi complex and microtubules in skeletal muscle is fiber type-dependent.

Authors:  E Ralston; Z Lu; T Ploug
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

3.  Regional differences in fibre type composition in the human temporalis muscle.

Authors:  J A Korfage; T M Van Eijden
Journal:  J Anat       Date:  1999-04       Impact factor: 2.610

4.  Golgi complex, endoplasmic reticulum exit sites, and microtubules in skeletal muscle fibers are organized by patterned activity.

Authors:  E Ralston; T Ploug; J Kalhovde; T Lomo
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

5.  Critical regulatory domains in intron 2 of a porcine sarcomeric myosin heavy chain gene.

Authors:  K C Chang
Journal:  J Muscle Res Cell Motil       Date:  2000       Impact factor: 2.698

6.  Muscle fibre types in the suprahyoid muscles of the rat.

Authors:  A R Cobos; L A Segade; I Fuentes
Journal:  J Anat       Date:  2001-03       Impact factor: 2.610

7.  Differential expression of SM22 isoforms in myofibroblasts and smooth muscle cells from rabbit bladder.

Authors:  A Chiavegato; M Roelofs; R Franch; E Castellucci; F Sarinella; S Sartore
Journal:  J Muscle Res Cell Motil       Date:  1999-02       Impact factor: 2.698

8.  MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type.

Authors:  H Wu; F J Naya; T A McKinsey; B Mercer; J M Shelton; E R Chin; A R Simard; R N Michel; R Bassel-Duby; E N Olson; R S Williams
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

9.  Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved.

Authors:  A Weiss; D McDonough; B Wertman; L Acakpo-Satchivi; K Montgomery; R Kucherlapati; L Leinwand; K Krauter
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

Review 10.  Aging-related changes in skeletal muscle. Mechanisms and interventions.

Authors:  L Larsson; B Ramamurthy
Journal:  Drugs Aging       Date:  2000-10       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.